Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary F Mulcahy

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
Gastrointestinal Cancer Research : GCR|May 23, 2009
Radiotherapy for cancer of the rectum: which patients stand to benefit?Mary F Mulcahy
Seminars in Oncology|August 7, 2007
Adjuvant therapy for pancreas cancer: advances and controversiesMary F Mulcahy
Biologics : Targets & Therapy|August 27, 2009
Bevacizumab in the therapy for refractory metastatic colorectal cancerMary F Mulcahy
Current Treatment Options in Oncology|August 19, 2005
Management of hepatocellular cancerMary F Mulcahy
Clinical Advances in Hematology & Oncology : H&O|May 12, 2007
Liver resection after FOLFOX with bevacizumabMarcia Mickle, Mary F Mulcahy
Current Oncology Reports|April 19, 2006
Adjuvant therapy for colon cancerJeffrey Cilley, Mary F Mulcahy
Journal of the National Comprehensive Cancer Network : JNCCN|June 8, 2013
Treatment of early-stage esophageal adenocarcinomaAriel Polish, Mary F Mulcahy
Expert Opinion on Investigational Drugs|May 31, 2002
Recent and ongoing clinical trials for treating colorectal cancerMary F Mulcahy, Al B Benson
Expert Opinion on Biological Therapy|July 16, 2005
Bevacizumab in the treatment of colorectal cancerMary F Mulcahy, Al B Benson
Journal of Surgical Oncology|December 8, 2023
Evolution of therapy for locally advanced rectal cancerNicole J Altomare, Mary F Mulcahy
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
Gastrointestinal Cancer Research : GCR|May 23, 2009
Radiotherapy for cancer of the rectum: which patients stand to benefit?Mary F Mulcahy
Seminars in Oncology|August 7, 2007
Adjuvant therapy for pancreas cancer: advances and controversiesMary F Mulcahy
Biologics : Targets & Therapy|August 27, 2009
Bevacizumab in the therapy for refractory metastatic colorectal cancerMary F Mulcahy
Current Treatment Options in Oncology|August 19, 2005
Management of hepatocellular cancerMary F Mulcahy
Clinical Advances in Hematology & Oncology : H&O|May 12, 2007
Liver resection after FOLFOX with bevacizumabMarcia Mickle, Mary F Mulcahy
Current Oncology Reports|April 19, 2006
Adjuvant therapy for colon cancerJeffrey Cilley, Mary F Mulcahy
Journal of the National Comprehensive Cancer Network : JNCCN|June 8, 2013
Treatment of early-stage esophageal adenocarcinomaAriel Polish, Mary F Mulcahy
Expert Opinion on Investigational Drugs|May 31, 2002
Recent and ongoing clinical trials for treating colorectal cancerMary F Mulcahy, Al B Benson
Expert Opinion on Biological Therapy|July 16, 2005
Bevacizumab in the treatment of colorectal cancerMary F Mulcahy, Al B Benson
Journal of Surgical Oncology|December 8, 2023
Evolution of therapy for locally advanced rectal cancerNicole J Altomare, Mary F Mulcahy
Pageof 16